Filing Details
- Accession Number:
- 0001209191-21-006323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-29 20:13:23
- Reporting Period:
- 2021-01-28
- Accepted Time:
- 2021-01-29 20:13:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780556 | David Jakeman | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-28 | 3,211 | $8.61 | 96,906 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 24, 2017, January 25, 2018, January 23, 2019 and January 21, 2020. The sales of the shares were made pursuant to automatic sell-to-cover arrangements adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grants of such restricted stock unit awards.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.61 to $8.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.